These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2664173)

  • 41. [Treatment of primary fibromyalgia with Rheumajecta and Vasolastine; results of a randomized, placebo-controlled, double-blind study].
    Nollen AJ
    Ned Tijdschr Geneeskd; 1990 May; 134(21):1062-3. PubMed ID: 2164164
    [No Abstract]   [Full Text] [Related]  

  • 42. A comparison of cyclobenzaprine and placebo in the management of fibrositis. A double-blind controlled study.
    Bennett RM; Gatter RA; Campbell SM; Andrews RP; Clark SR; Scarola JA
    Arthritis Rheum; 1988 Dec; 31(12):1535-42. PubMed ID: 3058130
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical results of ibuprofen (Brufen) in abarticular rheumatism].
    Suţeanu S; Blaja V; Moangă M
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1976; 28(6):435-8. PubMed ID: 14381
    [No Abstract]   [Full Text] [Related]  

  • 44. Evaluation of amitriptyline in primary fibrositis. A double-blind, placebo-controlled study.
    Carette S; McCain GA; Bell DA; Fam AG
    Arthritis Rheum; 1986 May; 29(5):655-9. PubMed ID: 3521612
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of Panax ginseng extract in patients with fibromyalgia: a 12-week, randomized, double-blind, placebo-controlled trial.
    Braz AS; Morais LC; Paula AP; Diniz MF; Almeida RN
    Braz J Psychiatry; 2013 Mar; 35(1):21-8. PubMed ID: 23567596
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Treatment of primary fibromyalgia using Rheumajecta and Vasolastine; results of a randomized, placebo-controlled, double-blind study].
    Hissink Muller W
    Ned Tijdschr Geneeskd; 1990 Jul; 134(27):1321-2. PubMed ID: 2115620
    [No Abstract]   [Full Text] [Related]  

  • 47. A double-blind crossover study of two cyclobenzaprine regimens in primary fibromyalgia syndrome.
    Santandrea S; Montrone F; Sarzi-Puttini P; Boccassini L; Caruso I
    J Int Med Res; 1993; 21(2):74-80. PubMed ID: 8243792
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Double-blind study of dothiepin versus placebo in the treatment of primary fibromyalgia syndrome.
    Caruso I; Sarzi Puttini PC; Boccassini L; Santandrea S; Locati M; Volpato R; Montrone F; Benvenuti C; Beretta A
    J Int Med Res; 1987; 15(3):154-9. PubMed ID: 3301454
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chlormezanone in primary fibromyalgia syndrome: a double blind placebo controlled study.
    Pattrick M; Swannell A; Doherty M
    Br J Rheumatol; 1993 Jan; 32(1):55-8. PubMed ID: 8422561
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A double-blind dose-ranging trial with paediatric ibuprofen.
    Marriott SC; Stephenson TJ
    Br J Clin Pract Suppl; 1990 Aug; 70():15-8. PubMed ID: 2081103
    [No Abstract]   [Full Text] [Related]  

  • 51. Ibuprofen in the treatment of acute ankle joint injuries. A double-blind study.
    Fredberg U; Hansen PA; Skinhøj A
    Am J Sports Med; 1989; 17(4):564-6. PubMed ID: 2675651
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oral S-adenosylmethionine in primary fibromyalgia. Double-blind clinical evaluation.
    Jacobsen S; Danneskiold-Samsøe B; Andersen RB
    Scand J Rheumatol; 1991; 20(4):294-302. PubMed ID: 1925418
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of fibromyalgia (fibrositis syndrome): a parallel double blind trial with carisoprodol, paracetamol and caffeine (Somadril comp) versus placebo.
    Vaerøy H; Abrahamsen A; Førre O; Kåss E
    Clin Rheumatol; 1989 Jun; 8(2):245-50. PubMed ID: 2667860
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A randomised double-blind 16-week study of ritanserin in fibromyalgia syndrome: clinical outcome and analysis of autoantibodies to serotonin, gangliosides and phospholipids.
    Olin R; Klein R; Berg PA
    Clin Rheumatol; 1998; 17(2):89-94. PubMed ID: 9641502
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Double-blind study of 5-hydroxytryptophan versus placebo in the treatment of primary fibromyalgia syndrome.
    Caruso I; Sarzi Puttini P; Cazzola M; Azzolini V
    J Int Med Res; 1990; 18(3):201-9. PubMed ID: 2193835
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of fibromyalgia syndrome with Super Malic: a randomized, double blind, placebo controlled, crossover pilot study.
    Russell IJ; Michalek JE; Flechas JD; Abraham GE
    J Rheumatol; 1995 May; 22(5):953-8. PubMed ID: 8587088
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Primary fibromyalgia syndrome and 5-hydroxy-L-tryptophan: a 90-day open study.
    Sarzi Puttini P; Caruso I
    J Int Med Res; 1992 Apr; 20(2):182-9. PubMed ID: 1521674
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Ibuprofen in the long-term treatment of coxarthrosis. Controlled open study].
    Pavelka K; Vojtísek O; Susta A; Salavcová V
    Fysiatr Revmatol Vestn; 1977 Apr; 55(2):65-70. PubMed ID: 558145
    [No Abstract]   [Full Text] [Related]  

  • 59. Efficacy of low power laser therapy in fibromyalgia: a single-blind, placebo-controlled trial.
    Gür A; Karakoç M; Nas K; Cevik R; Saraç J; Demir E
    Lasers Med Sci; 2002; 17(1):57-61. PubMed ID: 11845369
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of S-adenosylmethionine in primary fibromyalgia. A double-blind crossover study.
    Tavoni A; Vitali C; Bombardieri S; Pasero G
    Am J Med; 1987 Nov; 83(5A):107-10. PubMed ID: 3318438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.